U.S. Contrast Media Market Size, Share & Trends Analysis Report By Modality (Modality, Ultrasound, Magnetic Resonance Imaging (MRI), X-ray/Computed Tomography (CT Scan)), By Type, By Application, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                          1.1.1. Type
                          1.1.2. Modality
                          1.1.3. Application
                          1.1.4. Estimates and forecast timeline
                      1.2. Research Methodology
                      1.3. Information Procurement
                          1.3.1. Purchased database
                          1.3.2. GVR’s internal database
                          1.3.3. Secondary sources
                          1.3.4. Primary research
                          1.3.5. Details of primary research
                      1.4. Information or Data Analysis
                      1.5. Market Formulation & Validation
                      1.6. Model Details
                      1.7. List of Secondary Sources
                      1.8. List of Primary Sources
                      1.9. Objectives
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Type outlook
                          2.2.2. Modality outlook
                          2.2.3. Application outlook
                      2.3. Competitive Insights
Chapter 3. U.S. Contrast Media Market Variables, Trends & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Penetration & Growth Prospect Mapping
                      3.3. Market Dynamics
                          3.3.1. Market driver analysis
                          3.3.2. Market restraint analysis
                              3.4. U.S. Contrast Media Market Analysis Tools
                          3.4.1. Industry Analysis - Porter’s
                              3.4.1.1. Supplier power
                              3.4.1.2. Buyer power
                              3.4.1.3. Substitution threat
                              3.4.1.4. Threat of new entrant
                              3.4.1.5. Competitive rivalry
                          3.4.2. PESTEL Analysis
                              3.4.2.1. Political landscape
                              3.4.2.2. Technological landscape
                              3.4.2.3. Economic landscape
Chapter 4. U.S. Contrast Media: Type Estimates & Trend Analysis
                      4.1. U.S. Contrast Media Market, By Type Key Takeaways
                      4.2. U.S. Contrast Media Market: Movement & Market Share Analysis, 2022 & 2030
                      4.3. Microbubble Contrast Media
                          4.3.1. Microbubble contrast media market estimates and forecasts, 2018 to 2030 (USD Million)
                      4.4. Gadolinium-based Contrast Media
                          4.4.1. Gadolinium-based contrast media market estimates and forecasts, 2018 to 2030 (USD Million)
                      4.5. Iodinated Contrast Media
                          4.5.1. Iodinated contrast media market estimates and forecasts, 2018 to 2030 (USD Million)
                      4.6. Barium-based Contrast Media
                          4.6.1. Barium-based contrast media market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. U.S. Contrast Media: Modality Estimates & Trend Analysis
                      5.1. U.S. Contrast Media Market, By Modality Key Takeaways
                      5.2. U.S. Contrast Media Market: Movement & Market Share Analysis, 2022 & 2030
                      5.3. Ultrasound
                          5.3.1. Ultrasound market estimates and forecasts, 2018 to 2030 (USD Million)
                      5.4. Magnetic Resonance Imaging (MRI)
                          5.4.1. Magnetic resonance (MRI) imaging market estimates and forecasts, 2018 to 2030 (USD Million)
                      5.5. X-RAY/Computed Tomography (CT Scan)
                          5.5.1. X-RAY/computed tomography (CT Scan) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. U.S. Contrast Media: Application Estimates & Trend Analysis
                      6.1. U.S. Contrast Media Market, By Application Key Takeaways
                      6.2. U.S. Contrast Media Market: Movement & Market Share Analysis, 2022 & 2030
                      6.3. Cardiovascular
                          6.3.1. Cardiovascular market estimates and forecasts, 2018 to 2030 (USD Million)
                      6.4. Neurological Disorders
                          6.4.1. Neurological disorders market estimates and forecasts, 2018 to 2030 (USD Million)
                      6.5. Gastrointestinal Disorders
                          6.5.1. Gastrointestinal disorders market estimates and forecasts, 2018 to 2030 (USD Million)
                      6.6. Cancer
                          6.6.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
                      6.7. Nephrological Disorders
                          6.7.1. Nephrological disorders market estimates and forecasts, 2018 to 2030 (USD Million)
                      6.8. Musculoskeletal Disorders
                          6.8.1. Musculoskeletal disorders market estimates and forecasts, 2018 to 2030 (USD Million)
                      6.9. Others
                          6.9.1. Others market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
                      7.1. Recent Developments & Impact Analysis, By Key Market Participants
                      7.2. Company/Competition Categorization
                          7.2.1. Bayer AG
                              7.2.1.1. Company overview
                              7.2.1.2. Financial performance
                              7.2.1.3. Product benchmarking
                              7.2.1.4. Strategic initiatives
                          7.2.2. GE Healthcare
                              7.2.2.1. Company overview
                              7.2.2.2. Financial performance
                              7.2.2.3. Product benchmarking
                              7.2.2.4. Strategic initiatives
                          7.2.3. Guerbet
                              7.2.3.1. Company overview
                              7.2.3.2. Financial performance
                              7.2.3.3. Product benchmarking
                              7.2.3.4. Strategic initiatives
                          7.2.4. Lantheus Medical Imaging, Inc
                              7.2.4.1. Company overview
                              7.2.4.2. Financial performance
                              7.2.4.3. Product benchmarking
                              7.2.4.4. Strategic initiatives
                          7.2.5. Bracco Diagnostic Inc
                              7.2.5.1. Company overview
                              7.2.5.2. Financial performance
                              7.2.5.3. Product benchmarking
                              7.2.5.4. Strategic initiatives
                          7.2.6. Trivitron Healthcare
                              7.2.6.1. Company overview
                              7.2.6.2. Financial performance
                              7.2.6.3. Product benchmarking
                              7.2.6.4. Strategic initiatives
                          7.2.7. Nano Therapeutics Pvt Ltd.
                              7.2.7.1. Company overview
                              7.2.7.2. Financial performance
                              7.2.7.3. Product benchmarking
                              7.2.7.4. Strategic initiatives
                          7.2.8. IMAX Diagnostic Imaging
                              7.2.8.1. Company overview
                              7.2.8.2. Financial performance
                              7.2.8.3. Product benchmarking
                              7.2.8.4. Strategic initiatives
                          7.2.9. CMC Contrast AB (ASCELIA PHARMA AB)
                              7.2.9.1. Company overview
                              7.2.9.2. Financial performance
                              7.2.9.3. Product benchmarking
                              7.2.9.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. U.S. contrast media market, by type, 2018 - 2030 (USD Million)
Table 3 U.S. U.S. contrast media market, by modality, 2018 - 2030 (USD Million)
Table 4 U.S. U.S. contrast media market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. contrast media: Market outlook
Fig. 9 U.S. contrast media: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 U.S. contrast media market driver impact
Fig. 15 U.S. contrast media market restraint impact
Fig. 16 U.S. contrast media market strategic initiatives analysis
Fig. 17 U.S. contrast media market: Type movement analysis
Fig. 18 U.S. contrast media market: Type outlook and key takeaways
Fig. 19 Microbubble Contrast Media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Gadolinium-based Contrast Media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Iodinated Contrast Media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Barium-based Contrast media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 U.S. contrast media market: Modality movement analysis
Fig. 25 U.S. contrast media market: Modality outlook and key takeaways
Fig. 26 Ultrasound market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Magnetic resonance imaging (MRI) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 X-ray/computed tomography (CT scan) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. contrast media market: Application movement analysis
Fig. 30 U.S. contrast media market: Application outlook and key takeaways
Fig. 31 Cardiovascular conditions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Neurological disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Gastrointestinal disorders management market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Nephrological disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Musculoskeletal disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)